Event dossier

Abivax in no rush for a deal, confident key June trial data can secure better terms for partnerships, CEO tells CNBC

Analysts see the biotech company as a prime takeover target and several pharma giants have been rumored as potential buyers.

1 report1 sourceMar 24, 2026, 3:42 PM
FilterCNBC
Clustered coverageCNBC
Coverage timeline1
Coverage timeline

Coverage timeline

Ranked reports inside the event cluster. Open any publisher link to read the original coverage.

CNBCMar 24, 2026, 3:42 PM

Abivax in no rush for a deal, confident key June trial data can secure better terms for partnerships, CEO tells CNBC

Analysts see the biotech company as a prime takeover target and several pharma giants have been rumored as potential buyers.

Related events

Related events

Nearby clusters pulled from title, summary, and keyword similarity in PostgreSQL.

El Psy Congroo Newswire